Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Beta-2-microglobulin in hyperthyroidism].

G Foscolo1, I Roiter, E De Menis

  • 1I Divisione Medica, Ospedale Regionale, Treviso.

Minerva Endocrinologica
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disease control of acromegaly does not prevent excess mortality in the long term: results of a nationwide survey in Italy.

Journal of endocrinological investigation·2024
Same author

Correction to: Pegvisomant in acromegaly: an update.

Journal of endocrinological investigation·2017
Same author

Nutritional status of people living with HIV/AIDS in the Ratoma community medical center (Republic of Guinea).

Medecine et sante tropicales·2017
Same author

Pegvisomant in acromegaly: an update.

Journal of endocrinological investigation·2017
Same author

A multicenter experience on the prevalence of ARMC5 mutations in patients with primary bilateral macronodular adrenal hyperplasia: from genetic characterization to clinical phenotype.

Endocrine·2016
Same author

Acromegaly Is More Severe in Patients With AHR or AIP Gene Variants Living in Highly Polluted Areas.

The Journal of clinical endocrinology and metabolism·2016

Elevated serum beta 2-microglobulin (a marker of thyroid hyperfunction) is common in hyperthyroidism, likely due to overproduction. However, it does not correlate with thyroid hormone levels, limiting its use in assessing hyperthyroidism severity.

Area of Science:

  • Endocrinology
  • Clinical Biochemistry

Background:

  • Serum beta 2-microglobulin (β2M) elevation is observed in thyroid hyperfunction.
  • The precise cause of increased β2M in hyperthyroidism requires clarification.

Purpose of the Study:

  • To investigate the cause of elevated serum β2M in patients with hyperthyroidism.
  • To determine if β2M levels correlate with thyroid hormone concentrations or specific thyroid conditions.

Main Methods:

  • Serum β2M, free thyroid hormones, TSH, and autoantibodies were measured in 31 untreated hyperthyroid patients with normal renal function.
  • Patients included those with diffuse toxic goiter (n=21) and toxic adenoma (n=10).

Main Results:

  • Elevated β2M was found in 90% of diffuse toxic goiter cases and 70% of toxic adenoma cases.

Related Experiment Videos

  • No significant difference in mean β2M concentrations between the two groups.
  • β2M levels did not correlate with thyroid hormone concentrations or autoantibody presence.

    • Conclusions:

    • The elevated β2M in hyperthyroidism is primarily due to overproduction, likely hormone-mediated, in patients with normal renal function.
    • Lymphocyte activation may contribute to increased β2M in diffuse toxic goiter.
    • β2M is not a reliable marker for assessing hyperthyroidism severity due to lack of correlation with thyroid hormone levels.